West Covina, CA – According to filings with the U.S. Securities and Exchange Commission, Merion Inc. is raising $5,243,839.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Dinghua Wang played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Merion Inc.

Merion, Inc is a public US biotechnology company founded in Jan 2007 and registered in the State of Nevada. The head office is in Los Angeles, California. The Ticker Symbol is EWLU. With the purpose of helping people to improve their quality of their lives with great nutrition supplement products, we have been making great efforts to provide the best quality products, from the scientific research to manufacturing and packaging. Merion, Inc has its own exclusive biological small molecules nutrition formulation. With the worldwide top biotechnology R & D team, we development and produce 100% plants extracts small molecular nutrition supplements with cell carrier. Merion, Inc. continues to introduce high-tech small molecules +cell carrier nutrient products based on the market demand, and fully expand the market from online and offline through the e-commerce platform, which increases the sales year by year. As our fast development, we will further increase R&D and production of new products, strengthening the independent laboratory building, expand the production scale, increase market supply capacity to meet the needs of market development, especially in fast growing Asia-Pacific market. Our service aims to be honest, caring society and health and making deserved contribution for benefit mankind.

To learn more about Merion Inc., visit http://www.merionus.com/

Contact:
Dinghua Wang, Chief Executive Officer
626-331-7570
https://www.linkedin.com/in/dinghua-wang-bb7553178/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved